DELVE INTO AFRICAN WEALTH
DON'T MISS A BEAT
Subscribe now
Skip to content

Wealth Intelligence: The Molecule and the Map

Merck handed Aspen the right to make a once-monthly HIV pill across 129 countries. It is the second pharma prize Africa's largest drugmaker has landed this month.

Wealth Intelligence: The Molecule and the Map

The intelligence satisfies curiosity. The paid briefings satisfy strategy.

Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.

Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.

Executive ($25/mo): Daily newsletter + Deep-Dive Reports

Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings

Subscribe now

This post is for subscribers on the Billionaires.Africa: Elite tier

Subscribe

Already have an account? Sign In

Latest

The Inside Story: The Wells Others Left

The Inside Story: The Wells Others Left

In the early 1990s a French engineer bought an ageing Gabonese oil field that Amoco had written off. That single unwanted reservoir became the model for an $11.4 billion fortune built almost entirely on the barrels the majors abandoned across Africa.

Members Public